A pilot study of N-methyl-D-aspartate (NMDA) antagonist in Parkinson's disease.
Montastruc
J L
JL
Rascol
O
O
Senard
J M
JM
Rascol
A
A
D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa / Q000008:administration & dosage; D009460:Neurologic Examination / Q000187:drug effects; D010300:Parkinson Disease / Q000188:drug therapy*; D010865:Pilot Projects; D010880:Piperidines / Q000008:administration & dosage*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors*
D000978:Antiparkinson Agents; D010880:Piperidines; D016194:Receptors, N-Methyl-D-Aspartate; D007980:Levodopa; C010739:ifenprodil